CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 60 filers reported holding CYTOSORBENTS CORP in Q1 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116,430 | -47.6% | 61,931 | 0.0% | 0.00% | – |
| Q2 2023 | $222,332 | +7.3% | 61,931 | +0.7% | 0.00% | – |
| Q1 2023 | $207,231 | +113.9% | 61,493 | -1.6% | 0.00% | – |
| Q4 2022 | $96,860 | +16.7% | 62,490 | +1.9% | 0.00% | – |
| Q3 2022 | $83,000 | -38.1% | 61,339 | +0.6% | 0.00% | – |
| Q2 2022 | $134,000 | -27.2% | 60,977 | +5.7% | 0.00% | – |
| Q1 2022 | $184,000 | -7.5% | 57,684 | +21.3% | 0.00% | – |
| Q4 2021 | $199,000 | – | 47,543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 692,738 | $5,524,000 | 2.01% |
| Skylands Capital, LLC | 1,421,700 | $11,345,000 | 1.89% |
| SECTORAL ASSET MANAGEMENT INC | 1,629,989 | $12,999,000 | 1.12% |
| Winning Points Advisors, LLC | 286,200 | $1,142,990,000 | 0.97% |
| Redmile Group, LLC | 2,101,131 | $16,757,000 | 0.31% |
| Granahan Investment Management | 632,035 | $5,040,000 | 0.17% |
| Avenir Corp | 190,240 | $1,517,000 | 0.16% |
| Seelaus Asset Management LLC | 20,000 | $160,000 | 0.13% |
| Olympiad Research LP | 17,816 | $142,000 | 0.07% |
| HighMark Wealth Management LLC | 10,000 | $80,000 | 0.07% |